A History of Actos
Actos is a drug to control Type 2 diabetes and is manufactured by the pharmaceutical company Takeda. Its generic name is pioglitazone hydrochloride. In the United States, approximately 20 million people suffer from Type 2 diabetes. Because of this, millions of people rely on drugs like Actos to maintain healthy glucose levels. However, like many diabetes medications before it, Actos has been linked to serious side effects, such as bladder cancer.
If you or someone you love has been diagnosed with bladder cancer after taking Actos, you may be able to seek financial compensation. Contact a dedicated Actos attorney from Williams Kherkher today at 800-641-9810 to discuss your case.
An Actos Timeline
- 1996 – Existing diabetes drugs are shown to have devastating side effects
- 1999 – The FDA approves Actos for type 2 diabetes
- 2002 – Actos is listed on the FDA’s products that must warn of possible heart failure on the label
- 2007 – The FDA requires Actos to include a black-box warning for heart failure
- 2008 – Actos is the tenth best-selling medication in the US
- 2011 – The first Actos bladder cancer lawsuit is filed
The Actos lawsuit attorneys of Williams Kherkher believe that Takeda Pharmaceutical Company should be held accountable for the harm Actos has caused to those who have used it in good faith. You may be eligible to receive compensation for medical expenses and emotional trauma. If you would like to discuss an Actos lawsuit contact us by calling 800-641-9810 today.